Pathogenesis of calcium pyrophosphate deposition disease.

Charlene J Williams, Ann K Rosenthal

Journal: Best practice & research. Clinical rheumatology 2022;35(4):101718

PMID: 34696986

Abstract

Calcium pyrophosphate deposition disease is defined by the presence of calcium pyrophosphate (CPP) crystals in articular cartilage and is the fourth most common type of arthritis in adults. Despite its high prevalence, the etiology of CPPD disease remains unclear and no specific therapies currently exist. It has been known for several decades that abnormalities of cartilage pyrophosphate metabolism are common in patients with CPPD disease, and this classic work will be reviewed here. Recent studies of rare familial forms of CPPD disease have provided additional novel information about its pathophysiology. This work suggests that CPPD disease occurs through at least two unique and potentially intertwined biomolecular pathways. We are hopeful that a detailed understanding of the components and regulation of these pathways will lead to improved therapies for this common disease.

Published by Elsevier Ltd.

Address: Cooper Medical School of Rowan University, 401 S. Broadway, Camden, NJ 08103, USA. Electronic address: [email protected].; Clement J Zablocki Veterans Hospital, Medical College of Wisconsin, 5000 W. National Ave., Milwaukee, WI, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.